###begin article-title 0
###xml 51 55 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
B lymphocyte-specific, Cre-mediated mutagenesis in mice.
###end article-title 0
###begin p 1
###xml 161 165 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 231 235 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 399 403 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 409 413 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Adaptation of the P1 phage-derived Cre /loxP site- specific recombination system to the gene targeting technique allows for the conditional deletion of genes in mice. To selectively modify genes in B lymphocytes, we have generated mice (designated CD19-Cre) which express cre under the transcriptional control of the B lineage-restricted CD19 gene. In a model system involving the cross of CD19-Cre mice with mice bearing a loxP -flanked substrate, we find a deletion efficiency of 75-80% in bone marrow-derived pre-B cells that increases to 90-95% in splenic B cells.
###end p 1

